Abstract
Surgeons are frequently asked to evaluate and manage patients with pleural fluid collections. The clinical presentations and etiologies of pleural effusions can be a result of localized pleural disease or manifestations of systemic disease. This chapter reviews the anatomy and physiology of the pleural space, diagnostic techniques utilized in categorizing the pleural fluid, and the currently recommended therapeutic approaches for managing acute pleural effusion.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Rahman NM, Maskell NA, West A, et al. Intrapleural use of tissue plasminogen activator and DNase in pleural infection. N Engl J Med. 2011;365(6):518–26. https://doi.org/10.1056/nejmoa1012740.
Nielsen J, Meyer CN, Rosenlund S. Outcome and clinical characteristics in pleural empyema: a retrospective study. Scand J Infect Dis. 2011;43(6–7):430–5. https://doi.org/10.3109/00365548.2011.562527.
Reichert M, Hecker M, Witte B, et al. Stage-directed therapy of pleural empyema. Langenbecks Arch Surg. 2017;402(1):15–26.
Roberts HSA, Davies RJO, Davies CWH, Gleeson FV. BTS guidelines for the management of pleural infection [2] (multiple letters). Thorax. 2004;59(2):178.
Chen KY, Hsueh PR, Liaw YS, et al. A 10-year experience with bacteriology of acute thoracic empyema: emphasis on Klebsiella pneumoniae in patients with diabetes mellitus. Chest. 2000;117(6):1685–9. https://doi.org/10.1378/chest.117.6.1685.
Ingelfinger JR, Feller-Kopman D, Light R. Pleural disease. N Engl J Med. 2018;378(8):740–51.
Sperandeo M, Filabozzi P, Varriale A, et al. Role of thoracic ultrasound in the assessment of pleural and pulmonary diseases. J Ultrasound. 2008; https://doi.org/10.1016/j.jus.2008.02.001.
Park CK, Oh HJ, Choi HY, et al. Microbiological characteristics and predictive factors for mortality in pleural infection: a single-center cohort study in Korea. PLoS One. 2016;11(8):e0161280. https://doi.org/10.1371/journal.pone.0161280.
Bedawi EO, Hassan M, Rahman NM. Recent developments in the management of pleural infection: a comprehensive review. Clin Respir J. 2018;12(8):2309–20.
Maskell NA, Batt S, Hedley EL, et al. The bacteriology of pleural infection by genetic and standard methods and its mortality significance. Am J Respir Crit Care Med. 2006;174(7):817–23. https://doi.org/10.1164/rccm.200601-074OC.
Light RW. A new classification of parapneumonic effusions and empyema. Chest. 1995;108(2):299–301. https://doi.org/10.1378/chest.108.2.299.
Muers M. Streptokinase for empyema. Lancet. 2005;349(9064):1491–2. https://doi.org/10.1016/s0140-6736(05)62094-6.
Colice GL, Curtis A, Deslauriers J, et al. Medical and surgical treatment of parapneumonic effusions: an evidence-based guideline. Chest. 2000;118(4):1158–71. https://doi.org/10.1378/chest.118.4.1158.
Rahman NM, Kahan BC, Miller RF, et al. A clinical score (RAPID) to identify those at risk for poor outcome at presentation in patients with pleural infection. Chest. 2014;145(4):848–55. https://doi.org/10.1378/chest.13-1558.
Hecker A, Uhle F, Schwandner T, et al. Diagnostics, therapy and outcome prediction in abdominal sepsis: current standards and future perspectives. Langenbeck’s Arch Surg. 2014;399:11–22.
Cameron R, Davies HR. Intra-pleural fibrinolytic therapy versus conservative management in the treatment of adult parapneumonic effusions and empyema. Cochrane Database Syst Rev. 2008;(2):CD002312.
Tokuda Y, Matsushima D, Stein GH, Miyagi S. Intrapleural fibrinolytic agents for empyema and complicated parapneumonic effusions: a meta-analysis. Chest. 2006;129(3):783–90. https://doi.org/10.1378/chest.129.3.783.
Nie W, Liu Y, Ye J, et al. Efficacy of intrapleural instillation of fibrinolytics for treating pleural empyema and parapneumonic effusion: a meta-analysis of randomized control trials. Clin Respir J. 2014;8(3):281–91. https://doi.org/10.1111/crj.12068.
Wait MA, Sharma S, Hohn J, Dal Nogare A. A randomized trial of empyema therapy. Chest. 1997;111(6):1548–51. https://doi.org/10.1378/chest.111.6.1548.
Scarci M, Abah U, Solli P, et al. EACTS expert consensus statement for surgical management of pleural empyema. Eur J Cardiothorac Surg. 2015;48(5):642–53. https://doi.org/10.1093/ejcts/ezv272.
Clagett OT, Geraci JE. A procedure for the management of postpneumonectomy empyema. J Thorac Cardiovasc Surg. 1963;45:141–5.
Schneiter D, Grodzki T, Lardinois D, et al. Accelerated treatment of postpneumonectomy empyema: a binational long-term study. J Thorac Cardiovasc Surg. 2008;136(1):179–85. https://doi.org/10.1016/j.jtcvs.2008.01.036.
Zaheer S, Allen MS, Cassivi SD, et al. Postpneumonectomy empyema: results after the Clagett procedure. Ann Thorac Surg. 2006;82(1):279–86. https://doi.org/10.1016/j.athoracsur.2006.01.052.
Rusch VW. Pleural effusions: benign and malignant. In: Patterson GA, Cooper JD, Deslauriers J, et al., editors. Pearson’s thoracic and esophagial surgery. 3rd ed. Philadelphia: Churchill Livingston; 2008. p. 1042–54. (Chapter 85).
Wang NS. Anatomy of the pleura. Clin Chest Med. 1998;19(2):229–40. https://doi.org/10.1016/S0272-5231(05)70074-5.
Heffner J, Klein J. Recent advances in the diagnosis and management of malignant pleural effusions. Mayo Clin Proc. 2008;83(2):235–50. https://doi.org/10.4065/83.2.235.
Kataoka H. Pericardial and pleural effusions in decompensated chronic heart failure. Am Heart J. 2000;139(5):918–23. https://doi.org/10.1016/S0002-8703(00)90026-7.
Gonlugur TF, Gonlugur U. Transudated in malignancy: still a role for pleural fluid. Ann Acad Med Singap. 2008;37:760–3.
Roberts M, Neville E, Berrisford R, et al. Management of a malignant pleural effusion: British Thoracic Society pleural disease guideline 2010. Thorax. 2010;65(Suppl 2):ii32–40. https://doi.org/10.1136/thx.2010.136994.
Huggins JT, Sahn SA, Heidecker J, et al. Characteristics of trapped lung: pleural fluid analysis, manometry, and air-contrast chest CT. Chest. 2007;131(1):206–13. https://doi.org/10.1378/chest.06-0430.
Shaw P, Agarwal. Pleurodesis for malignant pleural effusions. Cochrane Database Syst Rev. 2009;(1):CD002916. https://doi.org/10.1002/14651858.CD0002916.pub2.
Tan C, Sedrakyan A, Browne J, et al. The evidence on the effectiveness of management for malignant pleural effusions: a systematic review. Eur Cardiothorac Surg. 2006;29(5):829–38. https://doi.org/10.1016/j.ejcts.2005.12.025.
Glazer M, Berkman N, Lafair JS, et al. Successful talc slurry pleurodesis in patients with nonmalignant pleural effusion. Chest. 2000;117(5):1404–9. https://doi.org/10.1378/chest.117.5.1404.
Goodman A, Davies C. Efficacy of short-term versus long-term chest tube drainage following talc slurry pleurodesis in patients with malignant pleural effusions: a randomized trial. Lung Cancer. 2006;54(1):51–5. https://doi.org/10.1016/j.lungcan.2006.06.004.
Steger V, Mika U, Toomes H, et al. Who gains most? A 10-year experience with 611 thoracoscopic talc pleurodeses. Ann Thorac Surg. 2007;83:1940–5.
Wilshire C, Gilbert C, Asciak R, et al. Multicenter review of tunneled pleural catheter implementation and use in patients with malignant pleural effusions. Chest. 2018;154(4):523A–4A. https://doi.org/10.1016/j.chest.2018.08.473.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Hecker, A., Padberg, W., Browder, T., Spain, D.A. (2021). Empyema and Effusions. In: Galante, J.M., Coimbra, R. (eds) Thoracic Surgery for the Acute Care Surgeon. Hot Topics in Acute Care Surgery and Trauma. Springer, Cham. https://doi.org/10.1007/978-3-030-48493-4_5
Download citation
DOI: https://doi.org/10.1007/978-3-030-48493-4_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-48492-7
Online ISBN: 978-3-030-48493-4
eBook Packages: MedicineMedicine (R0)